September 15, 2025 — Leads & Copy — MindWalk Holdings Corp. (NASDAQ: HYFT), a Bio-Native AI company, announced its first fiscal quarter 2026 financial results, ended July 31, 2025.
The company reported record revenue of $7.6 million, a 45% year-over-year increase, and continued operations revenue of $3.2 million, up 28%. Gross margin expanded to 53%, with gross profit at $4.0 million compared to $2.4 million the previous year. Both operating loss and adjusted EBITDA loss were reduced by nearly half, and the net loss improved to $3.0 million from $4.0 million. The cash balance at quarter-end was $5.0 million, supplemented by $16.1 million in net proceeds from a Netherlands divestiture.
MindWalk highlighted the soft launch of its rebrand, progress on its dengue vaccine program, and validation of its LensAI platform. CEO Dr. Jennifer Bath noted the strong first quarter reflected robust project growth and improved operating efficiency. She stated the divestiture of Netherlands operations generated $16.1 million, strengthening the balance sheet and enabling a sharper focus on AI-driven initiatives. The company is advancing its transformation into a fully integrated BioIntelligence company.
The company will host a live conference call and webcast to discuss these results and provide a corporate update on Monday, September 15, 2025, at 10:30AM ET.
Contact:
Dr. Jennifer Bath, CEO
USA / International Toll +1 (646) 307-1963
USA – Toll-Free (800) 715-9871
Canada – Toronto (647) 932-3411
Canada – Toll-Free (800) 715-9871
Webcast Attendee URL
https://events.q4inc.com/attendee/796370968
Source: MindWalk Holdings Corp.
